| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| T1015 |
Clinic visit/encounter, all-inclusive |
42,691 |
30,581 |
$4.25M |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,200 |
842 |
$1K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,096 |
969 |
$0.00 |
| 80053 |
Comprehensive metabolic panel |
1,082 |
855 |
$0.00 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
24,667 |
18,194 |
$0.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
613 |
437 |
$0.00 |
| 84443 |
Thyroid stimulating hormone (TSH) |
109 |
73 |
$0.00 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,730 |
1,458 |
$0.00 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
265 |
226 |
$0.00 |
| 87428 |
|
566 |
507 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
1,276 |
1,003 |
$0.00 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
293 |
262 |
$0.00 |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
90 |
87 |
$0.00 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
483 |
389 |
$0.00 |
| 90686 |
|
229 |
188 |
$0.00 |
| 3074F |
|
881 |
751 |
$0.00 |
| 80349 |
|
35 |
14 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
238 |
191 |
$0.00 |
| 3080F |
|
266 |
235 |
$0.00 |
| 80061 |
Lipid panel |
677 |
519 |
$0.00 |
| 3078F |
|
877 |
747 |
$0.00 |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,894 |
1,134 |
$0.00 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
4,359 |
2,795 |
$0.00 |
| 99201 |
|
660 |
415 |
$0.00 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
156 |
104 |
$0.00 |
| 3077F |
|
269 |
237 |
$0.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
36 |
14 |
$0.00 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
20 |
20 |
$0.00 |
| 81025 |
|
12 |
12 |
$0.00 |
| 81003 |
|
14 |
12 |
$0.00 |